Senior insider sale
EVP, Chief R&D Officer at BIOMARIN PHARMACEUTICAL INC — senior position signals high conviction
$381.9K
6.33K shares
What this filing means
FRIBERG GREGORY R plans to sell 6.33K shares of BIOMARIN PHARMACEUTICAL INC valued at approximately $381.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/26/2026ACC: 0001959173-26-001526
Officer· EVP, Chief R&D Officer
Since Feb 2026
6.33K
Shares to sell
$381.9K
Approx. market value
6.33K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
ESPP Purchase
Cash
10/31/2025
398.00Restricted Stock Vesting
Compensation
9/30/2025
5.93KTotal acquired6.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/31/2025 | ESPP Purchase Cash | 398.00 | — |
9/30/2025 | Restricted Stock Vesting Compensation | 5.93K | — |
| Total | 6.33K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
6.33K
Market value
$381.9K
2/26/2026
Total
Units
6.33K
Value
$381.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/26/2026 | 6.33K | $381.9K | NASDAQ | Planned |
| Total | 6.33K | $381.9K | ||